ID   OCUU-5
AC   CVCL_HF25
SY   OCUU5; Osaka City University Urology-5
DR   Wikidata; Q54931854
RX   PubMed=14534724;
RX   PubMed=15604581;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
RX   PubMed=14534724; DOI=10.3892/or.10.6.1947;
RA   Ikemoto, Shinichi
RA   Narita, Keisuke
RA   Yoshida, Naomasa
RA   Wada, Seiji
RA   Kishimoto, Taketoshi
RA   Sugimura, Kazunobu
RA   Nakatani, Tatsuya
RT   "Effects of tumor necrosis factor alpha in renal cell carcinoma.";
RL   Oncol. Rep. 10:1947-1955(2003).
//
RX   PubMed=15604581; DOI=10.1159/000081597;
RA   Ikemoto, Shinichi
RA   Sugimura, Kazunobu
RA   Yoshida, Naomasa
RA   Kuratsukuri, Katsuyuki
RA   Wada, Seiji
RA   Nakatani, Tatsuya
RT   "Comparative antitumor activity of 5-fluorouracil and
RT   5'-deoxy-5-fluorouridine in combination with interferon-alpha in
RT   renal cell carcinoma cell lines.";
RL   Urol. Int. 73:348-353(2004).
//